HIV-1 core protein fragments

Details HIV-1 core protein fragments HIV-1 core protein fragments

1995-06-07

1997-12-23

Smith, Lynette F.

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Virus or component thereof

4242041, 4241841, 4241881, 435 5, 435 71, 435 72, 530324, 530325, 530326, A61K 3921, A61K 3912, G01N 3353, C07K 500

Patent

active

057004692

ABSTRACT:
The present invention provides peptidal fragments of human immunodeficiency virus (HIV) which interact specifically with a particular human leucocyte antigen (HLA) class I molecule to stimulate cytotoxic T lymphocyte immunity.

REFERENCES:
patent: 4554088 (1985-11-01), Whitehead et al.
patent: 4629783 (1986-12-01), Cosand
patent: 4772547 (1988-09-01), Heimer et al.
patent: 4808536 (1989-02-01), Chang et al.
patent: 5395751 (1995-03-01), McMichael et al.
patent: 5459238 (1995-10-01), McMichael et al.
patent: 5480967 (1996-01-01), McMichael et al.
Butini, et al, 1994, "Comparative Analysis of HIV-Specific CTL Activity in Lymphoid Tissue and Peripheral Blood". Abstract J 306, J. Cell. Biochem. Suppl. 18B.
Webster's Ninth New Collegiate Dictionary, p. 602, 1990.
Sternberg, FEBS Letters, vol. 218, pp. 231-237 (1987).
Mills, J. Immunol., vol. 144, pp. 1677-1683 (1990).
Bouillet et al, Nature, vol. 339, pp. 473-475 (1989).
Harlow et al, Antibodies, A Laboratory manual, Cold Spring Harbor, pp. 77, 96, 97 (1988).
Fauci et al, Annals of Internal Med., vol. 110, pp. 373-385 (1989).
Kurth, AIDS Research & Human Retroviruses, vol. 7, pp. 425-433 (1991).
Koup et al, J. of Virology, vol. 68, pp. 4650-4655 (1994).
Gotch et al, International Immunology, vol. 2, pp. 707-712 (1990).
Choppin et al, Critical Reviews in Immunology, vol. 12, pp. 1-16 (1992).
Sanchez-Madrid, Proc. Natl. Acad. Sci. US, vol. 79, pp. 7489-7493 (1982).
Ferns et al, AIDS, vol. 3, pp. 829-834 (1989).
Mathiesen, Immunology, vol. 67, pp. 453-459 (1989).
Wahren et al, J. Acquired Immune Deficiency Syndrome, vol. 4, pp. 448-456 (1989).
Parekh et al, Int. Conf. On AIDs, Jun. 4-9, 1989, p. 651.
McMichael et al, J. Exp. Med., vol. 164, pp. 1397-1406 (1986).
Gotch et al, Nature, vol. 326, pp. 881-882 (1987).
Cellular and Molecular Immunology, A.K. Abbas et al Eds., W.B. Saunders Co., Philadelphia, PA, pp. 398-401 (1991).
Immunology, Third Ed., I.M. Roitt et al Eds., Mosby, St. Louis, pp. 2.4-2.8 (1993).
Graham et al, New England J. of Med., vol. 333, pp. 1331-1339 (1995).
Haynes, Science, vol. 260, pp. 1279-1286 (1993).
Monaco, Immunology Today, vol. 13, pp. 173-179 (1992).
Del Val et al, Cell, vol. 66, pp. 1145-1153 (1991).
Eisenlohr et al, J. Exp. Med., vol. 175, pp. 481-487 (1992).
Partidos et al, Immunology, vol. 77, pp. 262-266 (1992).
Hansen et al, Fundamental Immunology, Paul Ed., p. 609 (1993).
Koenig et al, Nature Med., vol. 1, pp. 330-336 (1995).
Meier et al, Science, vol. 270, pp. 1360-1362 (1995).
Kerkau er al, AIDS Res. Human Retro, vol. 5, pp. 613-620 (1989).
Immunology at a Glance, Second Edition, J.H.L. Playfair, Blackwell Scientific Publications, pp. 9-11 (1982).
Nature Biotechnology, vol. 14, p. 1527 (1996), "Recombinant Vaccines Inch Closer to the Clinic".
Nixon et al, AIDS, vol. 5, pp. 1049-1059 (1991).
Riviere et al, Journal of Virology, vol. 63, pp. 2270-2277 (1989).
Townsend et al, Cell, vol. 44, pp. 959-968 (1986).
Takahashi et al, Proc. Natl. Acad. Sci. USA, vol. 85, pp. 3105-3109 (1988).
Mullbacher et al, J. Immunological Methods, vol. 68, pp. 205-215 (1984).
Parish et al, J. Immunological Methods, vol. 58, pp. 225-237 (1983).
Letter of Opposition to European patent No. 0346022, dated Nov. 13, 1996, from Peter J. Smart to European Patent Office.
Letter of Opposition to European patent No. 0346022, dated Nov. 14, 1996, from Peter J. Smart to European Patent Office.
Communication of Notice of Opposition to European Patent No. 0346022 dated Dec. 23, 1996.
Letter of Opposition to European Patent No. 0412766 dated Dec. 22, 1994, from John Raynor to European Patent Office.
Communication of Notice of Opposition to European Patent No. 0412766 dated Jan. 17, 1995.
Observations of patent proprietor relating to Notice of Opposition to European patent No. 0412766 dated Jun. 23, 1995.
Communication from European Patent Office in Opposition to European Patent No. 0412766 dated Feb. 29, 1996.
Letter from Peter J. Smart to European patent Office iin Opposition to European Patent No. 0412766 dated Sep. 4, 1996.
Walker et al, Nature, vol. 328, pp. 345-348 (1987).
Webster's Ninth New Collegiate Dictionary, Merriam-Webster, Springfield, MA, pp. 871, 946, 1301 (1988).
Nixon et al, Abstract, British Society for Immunology Joint Meeting, "Cytotoxic T Cell (CTL) Response to HIV", Spring 1988.
Wahren et al, Journal of Virology, vol. 61, pp. 2017-2023 (1987).
Greene, Scientific American, pp. 99-105 (1993).
Brown, The Washington Post, Jun. 10, 1993, "AIDS Vaccine Trials Viewed with Caution".
Claverie et al, Eur. J. Immunol., vol. 18, pp. 1547-1553, (1988).
Nixon et al, Nature, vol. 336, pp. 484-487 (1988).
Fox, Bio/Technology, vol. 12, p. 128 (1994).
Rowland-Jones et al, Nature Medicine, vol. 1, pp. 59-63 (1995).
Walker et al, AIDS, vol. 4, pp. 177-184 (1990), "Editorial review cytotoxic T lymphocytes against HIV".
Van Kuyk et al, Journal of Immunology, vol. 153, pp. 4826-4833 (1994).
Kalams et al, XI International Conference on AIDS, "HIV-1-Specific cytotoxic T lymphocyte and Proliferative Responses in Peripheral Blood Mononuclear Cells (PBMC) of Subjects with Stable Non-progressing HIV-1 Infection" Abstracts vol. 1, Mo.A.391, pp. 11-12 (1996).
Buchbinder et al, XI International Conference on AIDS, "Long-term Non-progression in the San Francisco City Clinic Cohort", Abstracts vol. 1, Tu.C.553, p. 251 (1996).

Affiliated with

Also associated with

Rating

HIV-1 core protein fragments does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with HIV-1 core protein fragments, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and HIV-1 core protein fragments will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1800494